PPARalpha regulates the production of serum Vanin-1 by liver

FEBS Letters

Volumn 587, Issue 22, 2013, Pages 3742-3748

  Rommelaere, Samuel ^a,b   Millet, Virginie ^a,b   Gensollen, Thomas ^a,b   Bourges, Christophe ^a,b   Eeckhoute, Jérôme ^b   Hennuyer, Nathalie ^b   Baugé, Eric ^b   Chasson, Lionel ^a,b   Cacciatore, Ivana ^d   Staels, Bart ^b   Pitari, Giuseppina ^c   Galland, Franck ^a,b   Naquet, Philippe ^a,b  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

Liver; Pantetheinase; PPARalpha; Vanin

Indexed keywords

CYSTEINE; HYDROLASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SERUM VANIN 1; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; LIVER; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SERUM;

LIVER; PANTETHEINASE; PPARALPHA; VANIN;

AMIDOHYDROLASES; ANIMALS; CACO-2 CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HEPATOCYTES; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; PPAR ALPHA;

EID: 84887406688     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.09.046     Document Type: Article

References (39)

1. S. Dupre, and D. Cavallini Purification and properties of pantetheinase from horse kidney Methods Enzymol. 62 1979 262 267
2. S. Dupre, R. Chiaraluce, M. Nardini, C. Cannella, G. Ricci, and D. Cavallini Continuous spectrophotometric assay of pantetheinase activity Anal. Biochem. 142 1984 175 181
3. F. Martin, M.F. Penet, F. Malergue, H. Lepidi, A. Dessein, and F. Galland Vanin-1(-/-) mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores J. Clin. Invest. 113 2004 591 597
4. O.W. Griffith, A. Larsson, and A. Meister Inhibition of gamma-glutamylcysteine synthetase by cystamine: an approach to a therapy of 5-oxoprolinuria (pyroglutamic aciduria) Biochem. Biophys. Res. Commun. 79 1977 919 925
5. F. Martin, F. Malergue, G. Pitari, J.M. Philippe, S. Philips, and C. Chabret Vanin genes are clustered (human 6q22-24 and mouse 10A2B1) and encode isoforms of pantetheinase ectoenzymes Immunogenetics 53 2001 296 306
6. G. Min-Oo, A. Fortin, G. Pitari, M. Tam, M.M. Stevenson, and P. Gros Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus J. Exp. Med. 204 2007 511 524
7. M. Aurrand-Lions, F. Galland, H. Bazin, V.M. Zakharyev, B.A. Imhof, and P. Naquet Vanin-1, a novel GPI-linked perivascular molecule involved in thymus homing Immunity 5 1996 391 405
8. M.J. Wilson, P. Jeyasuria, K.L. Parker, and P. Koopman The transcription factors steroidogenic factor-1 and SOX9 regulate expression of Vanin-1 during mouse testis development J. Biol. Chem. 280 2005 5917 5923
9. S. Grimmond, N. Van Hateren, P. Siggers, R. Arkell, R. Larder, and M.B. Soares Sexually dimorphic expression of protease nexin-1 and vanin-1 in the developing mouse gonad prior to overt differentiation suggests a role in mammalian sexual development Hum. Mol. Genet. 9 2000 1553 1560
10. G. Pitari, F. Malergue, F. Martin, J.M. Philippe, M.T. Massucci, and C. Chabret Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice FEBS Lett. 483 2000 149 154
11. C. Berruyer, F.M. Martin, R. Castellano, A. Macone, F. Malergue, and S. Garrido-Urbani Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress Mol. Cell. Biol. 24 2004 7214 7224
12. K.J. Dammanahalli, S. Stevens, and R. Terkeltaub Vanin-1 pantetheinase drives smooth muscle cell activation in post-arterial injury neointimal hyperplasia PLoS One 7 2012 e39106
13. K. Yamazaki, J. Kuromitsu, and I. Tanaka Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator-activated receptor alpha agonists Biochem. Biophys. Res. Commun. 290 2002 1114 1122
14. J.S. Moffit, P.H. Koza-Taylor, R.D. Holland, M.S. Thibodeau, R.D. Beger, and M.P. Lawton Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate Toxicol. Appl. Pharmacol. 222 2007 169 179
15. C. Berruyer, L. Pouyet, V. Millet, F.M. Martin, A. LeGoffic, and A. Canonici Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity J. Exp. Med. 203 2006 2817 2827
16. C. Roisin-Bouffay, R. Castellano, R. Valero, L. Chasson, F. Galland, and P. Naquet Mouse vanin-1 is cytoprotective for islet beta cells and regulates the development of type 1 diabetes Diabetologia 51 2008 1192 1201
17. P.A. Jansen, M. Kamsteeg, D. Rodijk-Olthuis, I.M. van Vlijmen-Willems, G.J. de Jongh, and M. Bergers Expression of the vanin gene family in normal and inflamed human skin: induction by proinflammatory cytokines J. Invest. Dermatol. 129 2009 2167 2174
18. C.T. Wittwer, C. Schweitzer, J. Pearson, W.O. Song, C.T. Windham, and B.W. Wyse Enzymes for liberation of pantothenic acid in blood: use of plasma pantetheinase Am. J. Clin. Nutr. 50 1989 1072 1078
19. S.S. Lee, T. Pineau, J. Drago, E.J. Lee, J.W. Owens, and D.L. Kroetz Targeted disruption of the alpha isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Mol. Cell. Biol. 15 1995 3012 3022
20. T.E. Akiyama, C.J. Nicol, C. Fievet, B. Staels, J.M. Ward, and J. Auwerx Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines J. Biol. Chem. 276 2001 39088 39093
21. F. Lalloyer, K. Wouters, M. Baron, S. Caron, E. Vallez, and J. Vanhoutte Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice Arterioscler. Thromb. Vasc. Biol. 31 2011 1573 1579
22. M.R. Vernsten, R. Maynette, W.C. Braaten, and M.B. Moore The preparation of crystalline dl-pantothenamide J. Am. Chem. Soc. 76 1954 5811
23. C.T. Wittwer, D. Burkhard, K. Ririe, R. Rasmussen, J. Brown, and B.W. Wyse Purification and properties of a pantetheine-hydrolyzing enzyme from pig kidney J. Biol. Chem. 258 1983 9733 9738
24. B.H. Ruan, D.C. Cole, P. Wu, A. Quazi, K. Page, and J.F. Wright A fluorescent assay suitable for inhibitor screening and vanin tissue quantification Anal. Biochem. 399 2010 284 292
25. S. Li, Z. Tang, H. Yu, W. Li, Y. Jiang, and Y. Wang Administration of naked plasmid encoding hepatic stimulator substance by hydrodynamic tail vein injection protects mice from hepatic failure by suppressing the mitochondrial permeability transition J. Pharmacol. Exp. Ther. 338 2011 750 757
26. M. Boergesen, T.A. Pedersen, B. Gross, S.J. van Heeringen, D. Hagenbeek, and C. Bindesboll Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor alpha in mouse liver reveals extensive sharing of binding sites Mol. Cell. Biol. 32 2012 852 867
27. Y. Zhang, T. Liu, C.A. Meyer, J. Eeckhoute, D.S. Johnson, and B.E. Bernstein Model-based analysis of ChIP-Seq (MACS) Genome Biol. 9 2008 R137
28. S. Granjeaud, P. Naquet, and F. Galland An ESTs description of the new Vanin gene family conserved from fly to human Immunogenetics 49 1999 964 972
29. M. Rakhshandehroo, B. Knoch, M. Muller, and S. Kersten Peroxisome proliferator-activated receptor alpha target genes PPAR Res. 2010 2010
30. S.R. Pyper, N. Viswakarma, S. Yu, and J.K. Reddy PPARalpha: energy combustion, hypolipidemia, inflammation and cancer Nucl. Recept. Signal. 8 2010 e002
31. T.C. Leone, C.J. Weinheimer, and D.P. Kelly A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders Proc. Natl. Acad. Sci. USA 96 1999 7473 7478
32. N.R. Katz Metabolic heterogeneity of hepatocytes across the liver acinus J. Nutr. 122 1992 843 849
33. C. Bocos, and E. Herrera Pantethine stimulates lipolysis in adipose tissue and inhibits cholesterol and fatty acid synthesis in liver and intestinal mucosa in the normolipidemic rat Environ. Toxicol. Pharmacol. 6 1998 59 66
34. P.A. Jansen, J.A. van Diepen, B. Ritzen, P.L. Zeeuwen, I. Cacciatore, and C. Cornacchia Discovery of small molecule vanin inhibitors: new tools to study metabolism and disease ACS Chem. Biol. 8 3 2013 530 534
35. R. Dohil, L. Meyer, S. Schmeltzer, B.L. Cabrera, J.E. Lavine, and S.A. Phillips The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects J. Pediatr. 161 639-645 2012 e631
36. J.K. Reddy, and T. Hashimoto Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system Annu. Rev. Nutr. 21 2001 193 230
37. F.J. Gonzalez, and Y.M. Shah PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators Toxicology 246 2008 2 8
38. J.K. Reddy, D.L. Azarnoff, and C.E. Hignite Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens Nature 283 1980 397 398
39. A.P. Fejes, G. Robertson, M. Bilenky, R. Varhol, M. Bainbridge, and S.J. Jones FindPeaks 3.1: a tool for identifying areas of enrichment from massively parallel short-read sequencing technology Bioinformatics 24 2008 1729 1730